Department of Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Adv Exp Med Biol. 2017;1042:61-78. doi: 10.1007/978-981-10-6955-0_3.
DNA replication is a fundamental process required for the accurate and timely duplication of chromosomes. During late mitosis to G1 phase, the MCM2-7 complex is loaded onto chromatin in a manner dependent on ORC, CDC6, and Cdt1, and chromatin becomes licensed for replication. Although every eukaryotic organism shares common features in replication control, there are also some differences among species. For example, in higher eukaryotic cells including human cells, no strict sequence specificity has been observed for replication origins, unlike budding yeast or bacterial replication origins. Therefore, elements other than beyond DNA sequences are important for regulating replication. For example, the stability and precise positioning of nucleosomes affects replication control. However, little is known about how nucleosome structure is regulated when replication licensing occurs. During the last decade, histone acetylation enzyme HBO1, chromatin remodeler SNF2H, and histone chaperone GRWD1 have been identified as chromatin-handling factors involved in the promotion of replication licensing. In this review, we discuss how the rearrangement of nucleosome formation by these factors affects replication licensing.
DNA 复制是染色体准确且及时复制所必需的基本过程。在有丝分裂晚期到 G1 期,MCM2-7 复合物以依赖 ORC、CDC6 和 Cdt1 的方式加载到染色质上,染色质被许可进行复制。尽管每个真核生物在复制控制方面都具有共同的特征,但物种之间也存在一些差异。例如,在包括人类细胞在内的高等真核细胞中,与芽殖酵母或细菌复制起点不同,复制起点没有严格的序列特异性。因此,除了 DNA 序列之外的其他因素对于调节复制很重要。例如,核小体的稳定性和精确定位会影响复制控制。然而,对于复制许可发生时核小体结构如何被调节,我们知之甚少。在过去的十年中,组蛋白乙酰转移酶 HBO1、染色质重塑因子 SNF2H 和组蛋白伴侣 GRWD1 已被确定为参与促进复制许可的染色质处理因子。在这篇综述中,我们讨论了这些因子如何通过改变核小体的形成来影响复制许可。